TABLE 5.

Patient serum samples that tested positive for either IgG or IgM antibodies to VlsE and VlsE peptides

Peptide	% of serum samples with IgM or IgG reactivity
	Early localized disease	Disseminated disease	Total
Ct	17	64	35
N1	22	21	22
N2	9	57	27
N3	9	21	14
C2	13	7	11
C4	4	14	8
C6	65	100	78
VlsE	48	86	62